Literature DB >> 17989606

Tubular engraftment and myofibroblast differentiation of recipient-derived cells after experimental kidney transplantation.

Martine Broekema1, Martin C Harmsen, Jasper A Koerts, Theo G van Kooten, Gerjan Navis, Marja J A van Luyn, Eliane R Popa.   

Abstract

BACKGROUND: In human renal allografts, recipient-derived cells engrafted in various kidney substructures, have been detected in the long term after transplantation. Here we investigated tubular engraftment and myofibroblast differentiation of recipient-derived cells at short term after experimental kidney transplantation, during a previously described window of regeneration and possible onset of renal interstitial fibrosis.
METHODS: Fisher (F344, syngeneic) and Dark Agouti (DA, allogeneic) kidneys were transplanted into F344-hPAP transgenic recipient rats, which allowed tracing of recipient-derived cells in nontransgenic donor kidneys. We evaluated tubular engraftment and myofibroblast differentiation of recipient-derived cells on day 14 after kidney transplantation.
RESULTS: Kidney transplantation resulted in tubular engraftment of recipient-derived cells. After allogeneic kidney transplantation, 9.7% of tubular cross-sections contained at least one recipient-derived cell, which represented a significant increase in comparison to syngeneic transplantation (4.0%, P<0.05). Moreover, recipient-derived myofibroblasts were present in the renal interstitium of the transplanted kidney. These cells contributed 39% of the total interstitial myofibroblast population in allografts, which was comparable to the syngeneic situation (28%, P=0.25).
CONCLUSIONS: In a defined early window of regeneration and possible onset of renal interstitial fibrosis after kidney transplantation, rejection-associated injury, superimposed on ischemic damage, increases tubular engraftment of recipient-derived cells, although it does not affect their relative contribution to the renal interstitial myofibroblast population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17989606     DOI: 10.1097/01.tp.0000285298.05242.f1

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

Review 1.  Renal erythropoietin-producing cells in health and disease.

Authors:  Tomokazu Souma; Norio Suzuki; Masayuki Yamamoto
Journal:  Front Physiol       Date:  2015-06-03       Impact factor: 4.566

2.  Interstitial fibroblasts in donor kidneys predict late posttransplant anemia.

Authors:  Aki Mafune Hamada; Izumi Yamamoto; Mayuko Kawabe; Haruki Katsumata; Takafumi Yamakawa; Ai Katsuma; Yasuyuki Nakada; Akimitsu Kobayashi; Yusuke Koike; Jun Miki; Hiroki Yamada; Takahiro Kimura; Yudo Tanno; Ichiro Ohkido; Nobuo Tsuboi; Hiroyasu Yamamoto; Mitsuyoshi Urashima; Takashi Yokoo
Journal:  Clin Kidney J       Date:  2019-09-24

Review 3.  Cardiac and renal cell therapies: similarities and differences.

Authors:  Christina M Takiya; Radovan Borojevic
Journal:  Kidney Int Suppl (2011)       Date:  2011-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.